Risk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Turkiye Cohort

dc.contributor.authorOğuz, Aytekin
dc.contributor.authorKilickap, Mustafa
dc.contributor.authorGulec, Sadi
dc.contributor.authorAltuntas, Yueksel
dc.contributor.authorKarsidag, Kubilay
dc.contributor.authorTemizhan, Ahmet
dc.contributor.authorÇaklılı, Özge Telci
dc.date.accessioned2025-05-10T19:34:51Z
dc.date.issued2023
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground: The risk of cardiovascular disease is correlated with the frequency and control of associated risk factors in diabetes mellitus and may vary according to country. We evaluated risk factors for cardiovascular disease, cardiovascular events, and the use of preventive medications in patients with diabetes mellitus using the Prospective Urban and Rural Epidemiological Turkiye cohort.Methods: Patients with diabetes mellitus versus without diabetes mellitus were com- pared for risk factors, cardioprotective drugs (angi otens in-co nvert ing enzyme inhibitors or angiotensin-II receptor antagonists, statins, and antiplatelets), and cardiovascular events. The primary outcome was major cardiovascular events (composite of cardiovas- cular death, myocardial infarction, stroke, or heart failure).Results: Among 4041 participants, 549 (13.6%) had diabetes mellitus. The mean age (54.8 & PLUSMN;8.4 vs. 49.3 & PLUSMN; 9.0 years, P < .001) and proportion of women (65.4% vs. 59.9%, P = .014) were higher in diabetics compared with non-diabetics. Hypertension, history of coronary heart disease, and use of statin, antiplatelets, and angiotensin-converting enzyme inhibitors or angiotensin-II receptor antagonists were more common in diabetics; however, the use of these medications at baseline was lower than optimal even in patients with diabetes mellitus and concomitant coronary heart disease (statin 31.2%, antiplatelets 46.9%, and angiotensin-converting enzyme inhibitors or angiotensin-II receptor antagonists 54.7%). During 11.5 years of follow-up, major cardiovascular events occurred in 288 (7.1%) patients, and the risk was higher in diabetics [hazard ratio (95% confidence interval) 1.71 (1.30-2.24); P < .001]. The increase in the risk of future events was comparable for those with diabetes mellitus alone without cardiovascular disease [hazard ratio 1.62 (1.20-2.20)] versus those with cardiovascular disease alone without diabetes mellitus [hazard ratio 1.31 (0.83-2.07)] and was additive in those with both conditions [hazard ratio 2.79 (1.65-4.69)]. The risk of major coronary events (myocardial infarction, angina, percutaneous, or surgical coronary intervention) was also higher in diabetes mellitus [hazard ratio 1.64 (1.26-2.15); P < .001].Conclusion: Patients with diabetes mellitus have a higher risk of major cardiovascular events, and the risk is comparable to that observed in those with cardiovascular disease but no diabetes mellitus. The use of preventive medicines for cardiovascular diseases is disturbingly low in diabetics.
dc.description.sponsorshipMetabolic Syndrome Society in Turkiye; Population Health Research Institute of McMaster University
dc.description.sponsorshipThis study was mainly supported by Metabolic Syndrome Society in Turkiye. The Population Health Research Institute of McMaster University provided financial and scientific support during the study.
dc.identifier.doi10.14744/AnatolJCardiol.2023.3465
dc.identifier.endpage+
dc.identifier.issn2149-2263
dc.identifier.issn2149-2271
dc.identifier.issue8
dc.identifier.pmid37439234
dc.identifier.scopus2-s2.0-85166391943
dc.identifier.scopusqualityQ3
dc.identifier.startpage453
dc.identifier.urihttps://doi.org/10.14744/AnatolJCardiol.2023.3465
dc.identifier.urihttps://hdl.handle.net/20.500.14730/8669
dc.identifier.volume27
dc.identifier.wosWOS:001073305700005
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherKare Publ
dc.relation.ispartofAnatolian Journal of Cardiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectDiabetes mellitus
dc.subjectcardiovascular events
dc.subjectmedications
dc.titleRisk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Turkiye Cohort
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
8669.pdf
Boyut:
2.46 MB
Biçim:
Adobe Portable Document Format